Vigil Neuro
Sharon Morani is a seasoned professional in facilities, operations, and corporate communications with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Director of Facilities & Operations at Vigil Neuroscience since June 2022, Sharon previously held significant roles at Atlas Venture and Rheos Medicines, Inc. Notably, Sharon's career includes a comprehensive background in executive assistance and operations management across various companies, including Jounce Therapeutics, where contributions focused on corporate communications and administrative support. Sharon's career trajectory reflects a commitment to enhancing operational efficiency and supporting executive leadership within the life sciences industry.
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.